Skip to main content
. 2017 Apr 17;101(12):1694–1698. doi: 10.1136/bjophthalmol-2017-310315

Table 3.

Treatment details

Prior to ITA initiation
 No of IVB injections
  1.25 mg (n=8) 16 (16, 2–35)
  2.0 mg (n=6) 7 (5, 3–15)
  2.5 mg (n=7) 16 (12, 3–35)
  3.0 mg (n=8) 10 (9, 1–19)
 IOP (mm Hg) 12 (12, 10–18)
After ITA initiation
 No of ITA injections 7 (7, 3–11)
 No of IVB injections 20 (20, 14–27)
 IOP 12 (12, 9–19)
 Months  of follow-up 21 (21, 15–28)

All values listed as mean (median, range).

IOP, intraocular pressure; ITA, intravitreal triamcinolone acetonide; IVB, intravitreal bevacizumab.